What are the next steps for vitamin C in sepsis?

Critical Care and Resuscitation

Volumn 20, Issue 3, 2018, Pages 172-173

  Udy, Andrew ^a,b   Fujii, Tomoko ^a,c   Luethi, Nora ^a  

^a MONASH UNIVERSITY   (Australia)

^b ALFRED HOSPITAL   (Australia)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; ASCORBIC ACID;

CLINICAL TRIAL (TOPIC); HUMAN; INTENSIVE CARE; SEPSIS;

ANTIOXIDANTS; ASCORBIC ACID; CLINICAL TRIALS AS TOPIC; CRITICAL CARE; HUMANS; SEPSIS;

EID: 85054375409     PISSN: 14412772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (16)

1. Kaukonen KM, Bailey M, Suzuki S, et al. Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000–2012. JAMA 2014; 311: 1308-16.
2. Venkatesh B, Finfer S, Cohen J, et al. Adjunctive glucocorticoid therapy in patients with septic shock. N Engl J Med 2018; 378: 797-808.
3. Sprung CL, Annane D, Keh D, et al. Hydrocortisone therapy for patients with septic shock. N Engl J Med 2008; 358: 111-24.
4. Eisen DP, Reid D, McBryde ES. Acetyl salicylic acid usage and mortality in critically ill patients with the systemic inflammatory response syndrome and sepsis. Crit Care Med 2012; 40: 1761-7.
5. Marik PE, Khangoora V, Rivera R, et al. Hydrocortisone, vitamin C, and thiamine for the treatment of severe sepsis and septic shock. Chest 2017; 151: 1229-38.
6. McNamara R, Deane AM, Anstey J, Bellomo R. Understanding the rationale for parenteral ascorbate (vitamin C) during an acute inflammatory reaction: a biochemical perspective. Crit Care Resusc 2018; 20: 174-9.
7. Amrein K, Oudemans-van Straaten HM, Berger MM. Vitamin therapy in critically ill patients: focus on thiamine, vitamin C, and vitamin D. Intensive Care Med 2018. doi: 10.1007/s00134-018-5107-y [Epub ahead of print]
8. Carr AC, Rosengrave PC, Bayer S, et al. Hypovitaminosis C and vitamin C deficiency in critically ill patients despite recommended enteral and parenteral intakes. Crit Care 2017; 21: 300.
9. Carr A, Frei B. Does vitamin C act as a pro-oxidant under physiological conditions? FASEB J 1999; 13: 1007-24.
10. Wilson JX. Evaluation of vitamin C for adjuvant sepsis therapy. Antioxid Redox Signal 2013; 19: 2129-40.
11. Parker WH, Qu ZC, May JM. Intracellular ascorbate prevents endothelial barrier permeabilization by thrombin. J Biol Chem 2015; 290: 21486-97.
12. Tyml K. Vitamin C and microvascular dysfunction in systemic inflammation. Antioxidants (Basel) 2017; 6: E49.
13. Barabutis N, Khangoora V, Marik PE, Catravas JD. Hydrocortisone and ascorbic acid synergistically prevent and repair lipopolysaccharide-induced pulmonary endothelial barrier dysfunction. Chest 2017; 152: 954-62.
14. Okamoto K, Tanaka H, Makino Y, Makino I. Restoration of the glucocorticoid receptor function by the phosphodiester compound of vitamins C and E, EPC-K1 (L-ascorbic acid 2-[3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2H-1-benzopyran-6-yl hydrogen phosphate] potassium salt), via a redox-dependent mechanism. Biochem Pharmacol 1998; 56: 79-86.
15. Fujita I, Hirano J, Itoh N, et al. Dexamethasone induces sodium-dependant vitamin C transporter in a mouse osteoblastic cell line MC3T3-E1. Br J Nutr 2001; 86: 145-9.
16. Carr A, Wohlrah C, Young P, Bellomo R. Stability of intravenous vitamin C solutions: a technical report. Crit Care Resusc 2018; 20: 180-1.